Aveanna Healthcare (NASDAQ:AVAH) Given New $4.50 Price Target at UBS Group
Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) had its price objective raised by stock analysts at UBS Group from $3.20 to $4.50 in a research note issued to investors on Friday,Benzinga reports. The firm currently has a “sell” rating on the stock. UBS Group’s price objective points to a potential downside of 13.29% from the […]
Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) had its price objective raised by stock analysts at UBS Group from $3.20 to $4.50 in a research note issued to investors on Friday,Benzinga reports. The firm currently has a “sell” rating on the stock. UBS Group’s price objective points to a potential downside of 13.29% from the […]
